Puma Biotechnology, Inc. (PBYI)

7.175 +0.28 (+4.14%) USD  |  NASDAQ  |  Jan 22, 10:14
More

Puma Biotechnology Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for PBYI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Nephros, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade